Skip to main content
. 2012 Feb 15;2012(2):CD003431. doi: 10.1002/14651858.CD003431.pub3

Lund 1997.

Methods RCT n=80
Participants CAF
Interventions GTN 0.2% bid 8 weeks vs. Placebo
Outcomes Healing 
 Headache 
 ARM, recurrence 
 Pain relief
Notes ROK 
 ITT ‐
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk ROK
Allocation concealment (selection bias) Low risk A ‐ Adequate
Selective reporting (reporting bias) Low risk appropriate outcomes/side effects reported
Other bias High risk ITT‐
Duration of Follow‐up 6 months or more High risk 8 weeks